PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.
- Bacteriuria - this refers to the presence of bacteria in the urine.
- Urinary tract infection (UTI) - this implies the presence of characteristic symptoms and significant bacteriuria from kidneys to bladder. Many laboratories regard 105 colony-forming units per millilitre (cfu/ml) as the threshold for diagnosing significant bacteriuria.
- Lower UTI - this is generally considered to be infection of the bladder (cystitis).
- Upper UTI - this includes pyelitis and pyelonephritis.
- Recurrent UTI - this may be due to relapse or re-infection.The number of recurrences regarded as clinically significant depends on age and sex.
- Uncomplicated UTI - this refers to infection of the urinary tract by a usual pathogen in a person with a normal urinary tract and with normal kidney function.
- Complicated UTI - this occurs where anatomical, functional, or pharmacological factors predispose the person to persistent infection, recurrent infection or treatment failure - eg, abnormal urinary tract.
Several micro-organisms are known to cause UTI, but the majority of infections will be produced by three organisms:
- Escherichia coli
- Staphylococcus saprophyticus
- Proteus mirabilis
Infection with less common organisms is more likely to occur in patients who have underlying pathology and/or frequent infections, are immunosuppressed, or who are catheterised. Organisms which may produce infection under these circumstances include:
- Klebsiella spp.
- Proteus vulgaris
- Candida albicans
- Pseudomonas spp.
UTIs are common in general practice, accounting for 1-3% of all consultations. Almost half of all women report at least one UTI sometime during their lifetime, and after an initial UTI, 20% to 30% of women experience a recurrence.
- UTIs occur much less frequently in men at all ages.
- Patients of either sex are more likely to develop a UTI if there is an abnormality of the renal tract or if there has been recent instrumentation of the renal tract.
- Antibiotic use changes the vaginal flora and promotes colonisation of the genital tract with E. coli, resulting in subsequent increased risk of UTI.
- Other risk factors associated with UTI include:
- Recent sexual activity
- New sexual partner
- Use of spermicide
- Presence of catheter
- Pregnancy - possible pregnancy should be sought in women of childbearing age
- Genetic component to risk - increased incidence of UTI in the immediate female relatives of women with recurrent UTI (also supported by the fact that UTIs are 3-4 times more likely to occur in women with certain blood groups).
A UTI can present with a range of symptoms, or may be totally asymptomatic and diagnosed only on routine dip testing. The presenting symptoms will vary with the age and sex of the patient and also with the severity and site of the infection but may include:
- Urinary frequency
- Painful frequent passing of only small amounts of urine
- Foul-smelling ± cloudy urine
- Urinary incontinence
- Suprapubic or loin pain
- Nausea ± vomiting
- Acute confusional state - particularly elderly patients
The differential diagnosis will depend on the presenting symptoms:
- Many of the symptoms of a UTI can be seen in women with urethral syndrome who have no bacterial infection or in postmenopausal women with atrophic vaginitis and urethritis.
- Other infections of the genital tract such as with Candida albicans, herpes simplex, Chlamydia trachomatis and Gardnerella spp. may also produce similar symptoms in some women.
- In men, an enlarged or inflamed prostate may also present in a similar manner to a UTI.
Investigation of a patient with symptoms suggestive of a UTI may include:
- History - eg, any previous UTI, sexual history, antibiotic use, any history of renal tract abnormality or diabetes, use of immunosuppressant agents such as steroids, family history of UTI.
- Examination of the bladder and kidneys.
- Dipstick analysis of urine - may treat as bacterial if there are positive results for nitrite and/or leukocytes.
- Urine microscopy - leukocytes indicate presence of infection.
- Urine culture - to exclude the diagnosis or if high-risk (eg, pregnant, immunosuppressed, renal tract anomaly or if failed to respond to earlier empirical treatment). Urine culture should always be performed in men with a history suggestive of UTI regardless of the results of the dipstick test. Urine culture is not required for symptomatic lower UTI in non-pregnant women.
- An ultrasound evaluation of the upper urinary tract is recommended to rule out urinary obstruction or renal stone disease in acute uncomplicated pyelonephritis.
Indications for referral
Further investigations are rarely necessary in otherwise healthy females with lower tract infections, as underlying renal tract abnormalities are uncommon even in those patients with recurrent infections.
Referral for imaging or cystoscopy should be considered in patients who:
- Have persistently not responded to treatment.
- Have a history of renal tract disease or anomaly.
- Have haematuria.
- Are women with more than three confirmed infections in the preceding year (two confirmed infections in the case of men) with no known contributing comorbidity.
In addition to the above criteria, referral should be considered for men who have any suggestion of obstruction along the urinary tract - eg, enlarged prostate.
Some women may find it helpful to be made aware of the risk factors for recurrent infection. These include:
- Use of spermicide
- Frequent sexual intercourse
- New sexual partner
- Trimethoprim or nitrofurantoin remains the drug of first choice for the empirical treatment of uncomplicated UTI. 10-20% of E. coli infections may be resistant. Current recommendations suggest that the treatment period should be no longer than three days in women with uncomplicated UTI, although should remain at seven days for the treatment of UTIs in men.
- First-line therapy in mild cases of uncomplicated pyelonephritis is an oral fluoroquinolone for seven-ten days. The rate of fluoroquinolone-resistant E. coli is generally <10% in Europe, but local guidance may suggest an alternative.
- The use of topical oestrogen in postmenopausal women may be considered symptomatically, but should not be used for prevention.
- Prophylactic low-dose antibiotics to prevent recurrent UTI are recommended or post-intercourse prophylaxis for women in whom episodes of infection are associated with sexual intercourse. When prescribed appropriately, recurrence rates may be reduced by 95%. Standard regimes are 50 mg nitrofurantoin/day or 100 mg trimethoprim/day.
- OM-89 (Uro-Vaxom®) has been shown to be more effective than placebo in randomised trials and can be recommended for recurrent, uncomplicated UTI. Comparison vs antimicrobial prophylaxis has not yet been established.
- Probiotics are not yet universally accessible. It is reasonable to consider intravaginal probiotics L. rhamnosus GR-1 and L. reuteri RC-14 used once or twice weekly, where they are available.
- Paracetamol and/or non-steroidal anti-inflammatory drugs (NSAIDS) are of use for symptomatic relief. However, recent research suggests that diclofenac may also have the capacity to treat UTI caused by E. coli.
Comparisons of different management strategies (eg, delayed script, dipstick testing or sending MSU) all showed similar outcomes.
Ascending infection can occur leading to:
- Perinephric and intrarenal abscess
- Hydronephrosis or pyonephrosis
- Renal failure
Men with UTI may also have infection of the prostate.
Complications of untreated asymptomatic bacteriuria in pregnancy include:
- Pyelonephritis (in up to 40% of women)
- Preterm delivery and infants with low birth weight
Further reading & references
- Diagnosis of UTI (a quick reference guide for Primary care), GOV.UK (2014)
- Guidelines on Urological Infections; European Association of Urology (2015)
- Management of suspected bacterial urinary tract infection in adults; Scottish Intercollegiate Guidelines Network - SIGN (updated guidelines 2012)
- Foxman B; Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003 Feb;49(2):53-70.
- Foxman B, Manning SD, Tallman P, et al; Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol. 2002 Dec 15;156(12):1133-40.
- Finer G, Landau D; Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis. 2004 Oct;4(10):631-5.
- Guidelines on Urological Infections; European Association of Urology (Mar 2013)
- Cranberries for preventing urinary tract infections; Cochrane Summaries, Apr 2013
- Guidelines on the Management of Urinary and Male Genital Tract Infections, European Association of Urology (2008)
- Chung A, Arianayagam M, Rashid P; Bacterial cystitis in women. Aust Fam Physician. 2010 May;39(5):295-8.
- Mazumdar K, Dutta NK, Dastidar SG, et al; Diclofenac in the management of E. coli urinary tract infections. In Vivo. 2006 Sep-Oct;20(5):613-9.
- Little P, Moore MV, Turner S, et al; Effectiveness of five different approaches in management of urinary tract BMJ. 2010 Feb 5;340:c199. doi: 10.1136/bmj.c199.
- Foxman B; Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.
Prof Cathy Jackson
Dr Hayley Willacy
Dr John Cox